Abstract

BackgroundSpondyloarthritis (SpA) comprises a heterogeneous group of diseases sharing several clinical, biochemical and radiological features. Biomarkers for SpA are scarce and their validation in real practice is essential in predicting...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call